Clinical Trial: Efficacy of the pA1c(R)HI Postbiotic in Metabolic Regulation in Healthy Individuals With Hyperglycemia

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903870) titled 'Efficacy of the pA1c(R)HI Postbiotic in Metabolic Regulation in Healthy Individuals With Hyperglycemia' on Oct. 16.

Brief Summary: This study will evaluate the effects of pA1c(R)HI, a heat-inactivated postbiotic derived from the bacterium Pediococcus acidilactici, on blood glucose regulation and other aspects of metabolic health in adults with elevated blood glucose levels who do not have diagnosed diabetes.

The study will include approximately 100 adults aged 18 to 80 years with glycated hemoglobin (HbA1c) levels of 5.7% to less than 6.5%, a range consistent with prediabetes. A postbiotic is a preparation of inactivated microorgan...